Koxitor 60 is a selective COX-2 inhibitor formulated to support the clinical management of pain and inflammation associated with musculoskeletal and joint disorders.
Designed for physician-directed therapy, the formulation assists in addressing inflammatory pathways involved in joint discomfort, helping maintain mobility and daily functional activity.
Category : Tablets & Capsules
Get a QuoteKoxitor 60 contains Etoricoxib, a selective cyclooxygenase-2 (COX-2) inhibitor developed for the management of inflammatory pain conditions.
By selectively inhibiting the COX-2 enzyme responsible for prostaglandin synthesis, Etoricoxib helps reduce inflammation and pain signaling at the source. Its targeted mechanism supports symptom control while maintaining gastrointestinal tolerability compared to non-selective NSAIDs.
The formulation is intended for controlled use under medical supervision as part of comprehensive pain management strategies.
Composition
Etoricoxib 60 mg Tablets
Intended Use
Koxitor 60 Tablets are intended for the management of:
Treatment should be based on clinical evaluation and prescribed by a registered healthcare professional.
| Property | Details |
|---|---|
| Dosage Form: | Tablet |
| Therapeutic Category: | Selective COX-2 Inhibitor / NSAID |
| Pack Size: | 10 × 10 Alu-Alu |
| Route of Administration: | Oral |
| Brand: | Servochem |
